Belvedere Trading
MRNY icon

Belvedere Trading’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Belvedere Trading’s Portfolio MRNY Stock Details MRNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,080
Closed -$19.1K – 996
2025
Q3 		$19.1K Sell
1,080
-90
-8% -$1.86K ﹤0.01% 769
2025
Q2 		$27.5K Buy
1,170
+30
+3% +$739 ﹤0.01% 645
2025
Q1 		$31.5K Buy
+1,140
New +$43.8K ﹤0.01% 522

Other funds holding MRNY

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Belvedere Trading's MRNY Position: Q3 2025 in Review

Belvedere Trading sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q3 2025, closing a stake of 853 shares — an estimated $17.7K sold.

Belvedere Trading first reported a position in MRNY in Q1 2025 and held it in 2 quarters. The position peaked at $20.2K in Q1 2025. 13 funds tracked by Wall St. Rank hold MRNY as of Q3 2025.

  • Belvedere Trading reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q3 2025 after selling out during the quarter.
  • Belvedere Trading sold 853 YieldMax MRNA Option Income Strategy ETF shares in Q3 2025, an estimated $17.7K.
  • Belvedere Trading first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2025 and held it in 2 quarters.
  • Belvedere Trading's YieldMax MRNA Option Income Strategy ETF position peaked at $20.2K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q3 2025.

Based on Belvedere Trading's 13F filing for Q3 2025, filed 27 Oct 2025.